Intersuisse have upgraded ITD to a buy with a 12mth price target of 59c...thats 40% up on current price of 39c...longer term valuations around the $1 area.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025